Correlation between virulence of various strains of mycobacteria and their susceptibility to ethanolic extract of propolis (EEP). 1998

S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
Department of Microbiology and Immunology, Silesian Academy of Medicine, Zabrze-Rokitnica, Poland. mikroimm@friko3.onet.pl

Ethanol extract of propolis (EEP) has antibacterial, antiviral, antiprotozoal and antifungal properties, in addition to many biological effects. Our laboratory has demonstrated a synergistic effect of EEP and antibiotics on the growth of Staphylococcus aureus, and suggested that the bactericidal effect of EEP was expressed mainly on virulent mycobacteria rather than on non-virulent (attenuated) ones. The present study was designed to reconfirm the latter finding, by subjecting 17 different mycobacteria strains to EEP, and evaluating whether there is a correlation between the virulence of the mycobacteria strains studied and their susceptibility to EEP. Our findings demonstrate that while the four non-virulent strains studied are not susceptible to EEP, out of the 13 virulent strains studied seven are susceptible and six are resistant to it. These results suggest that while there is no full correlation between virulence of the mycobacteria tested and their susceptibility to EEP, the few strains that were resistant to EEP were non-virulent.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D011429 Propolis A resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances. Bee Bread,Bee Glue,Bread, Bee,Glue, Bee
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity

Related Publications

S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
January 1999, Zeitschrift fur Naturforschung. C, Journal of biosciences,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
January 1989, Zeitschrift fur Naturforschung. C, Journal of biosciences,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
February 2009, Molecules (Basel, Switzerland),
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
January 1990, Biochemistry international,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
January 1980, Przeglad lekarski,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
January 1978, Arzneimittel-Forschung,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
December 1958, Acta tuberculosea Japonica,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
January 1977, Arzneimittel-Forschung,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
December 1996, Journal of ethnopharmacology,
S Scheller, and H Kawalski, and K Oklek, and S Dworniczak, and T Matsuno, and K Waldemar-Klimmek, and M Rajca, and J Shani
January 2016, Oxidative medicine and cellular longevity,
Copied contents to your clipboard!